tirzepatide age approval Eli Lilly's gained FDA in December 2024 for treating moderate-to-severe obstructive sleep apnea in adults with obesity, after Phase III trials showed a 20% average weight loss and a roughly The Moody Longevity Trial: Volunteer

Addressing these conditions through appropriate treatment improves quality of life now while potentially enhancing weight loss outcomes later

doi: 10.1023/a:1015399204069 77 HanadaKUchidaTTsukamotoYWatadaMYamaguchiNYamamotoKet al

Compare this premium to the cost of separate oral L-carnitine supplementation ($15-30/month) when evaluating whether the convenience of a single injection justifies the added expense

For millions of people who have been curious about GLP-1s but hesitant about injections, this moment feels like science just removed a very sharp needle from the equation

During your consultation, our providers will review your medical history and determine whether semaglutide or tirzepatide may be appropriate for you